Biopta
Explants of Inflammatory Bowel Disease tissue in culture- Case Study: Using human blood vessels to determine dose and time-dependent activity of a novel therapy for renal and vascular diseases
- Fresh, functional human tissues and the prediction of drug safety
- Improving the prediction of oral bioavailability using fresh human intestinal tissue
Bioserve
- Obesity, Diet and Type II Diabetes Risk
- Obesity and Type II Diabetes Risk; A Multinational Study
- Fish and Dairy Consumption and reduced risk of breast Cancer
- Exercise and Reduced Breast Cancer Risk; A Multinational Study
- Physical Activity, Diet and Ovarian Cancer Risk
- Family History of Cancer in First-degree Relatives and Increased Cancer Risk: A Multinational Study
- Effects of Breast-feeding and Oral Contraception on the Risk of Recurrence in Breast Cancer: A Multinational Study
REPROCELL
- Novel culture medium using a small-molecule agonist of thrombopoietin receptor
- Human iPSC-derived hepatocytes ReproHepato™ for CYP assay and drug toxicity testing
- Development of a novel xeno-free medium for feeder-free culture of human stem cells
- Development of a Novel Medium for culturing Naïve iPS Cells
- Human iPS cell-derived neurons and their applications for disease model research and development
- Functional improvement of iPS cell-derived Hepatocyte (ReproHepato™) by utilizing 3D culture system
- Improvement of Human iPS Cell-Derived Hepatocyte Functionality Using 3D Culture System
- Human iPSC-derived hepatocytes and cardiomyocytes for drug toxicity testing
- Human iPS cell-Derived Cardiomyocytes ReproCardio2™ as an Analytic Tool for Large-scale Toxicity Screening
- Novel culture medium (ReproHSC™) for human hematopoietic stem cells with a small-molecule agonist of thrombopoietin receptor
Stemgent
- mRNA for Integration-free Cell Fate Manipulation
- Introduction to mRNA Reprogramming
- RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood
- A novel transfection protocol for deriving iPS cell lines from human blood-derived endothelial progenitor cells (EPCs) and adult human dermal fibroblasts using a cocktail of non-modified reprogramming and immune evasion mRNAs
- miRNA-facilitated self-replicative RNA (srRNA) reprogramming of endothelial progenitor cells (EPCs) derived from human peripheral blood and cord blood
- Use of non-modified RNAs for the derivation of clinically-relevant iPS cell lines from human blood, urine and skin cells using GMP-compliant reagents
- Generation of clinically compatible and genetically stable iPS cell lines from human peripheral and cord blood using microRNA-facilitated srRNA reprogramming
- RNA-mediated generation of integration-free iPS cell lines from late-outgrowth endothelial progenitor cells (L-EPCs) derived from human blood
- mRNA-based Methods for Cell Fate Manipulation
- NEW Human iPSC-derived sensory neurons and their potential as an alternative to primary DRG cells for drug discovery
Alvetex
- Cell culture under perfusion conditions reduces cellular metabolic stress and mimics the in vivo physiological environment in pancreatic cancer — a poster from the university of Oxford (UK) by Hughes D, Willenbrock F, Reddy S, Silva MA, Soonawalla Z, Mukherjee S, O'Neill E (2019).
- Side by side: An evaluation of 2D vs. 3D cell culture for High Throughput Screening in Drug Discovery
- Drug resistance mechanisms in FGFR-driven cancers
- Explants of Inflammatory Bowel Disease tissue in culture
- Target-based drug activity and post-translational and transcriptional analysis using ex vivo Alvetex Scaffold three-dimensional cell culture technology